A new study has found that it may be possible to reprogram immune cells to fight melanoma.
The study, conducted by researchers at the University of Texas Southwestern Medical Center, showed that mice who had their immune cells reprogrammed were able to fight off the cancer.
The researchers believe that this could potentially be a new way to treat melanoma, as well as other cancers.
While more research is needed, the findings suggest that reprogramming immune cells could be a promising new treatment option for melanoma.
In a new study published in the journal Nature, researchers have found that a specific type of immune cell can be reprogrammed to fight against melanoma, a deadly form of skin cancer.
The study was conducted by a team of researchers at the Stanford University School of Medicine, led by Dr. Michael J. Fischbach.
The team used a new technique known as CRISPR-Cas9 to reprogram a specific type of immune cell, called a macrophage, to target and kill melanoma cells.
Macrophages are a type of white blood cell that normally helps to protect the body against infection. However, in some cases, they can actually contribute to the growth and spread of cancer cells.
In the new study, the researchers found that by using CRISPR-Cas9 to edit a specific gene in macrophages, they could convert them into cells that would specifically target and kill melanoma cells.
The study is still in its early stages, and more research is needed to confirm the findings. However, if the findings are confirmed, this could lead to the development of new and potentially more effective treatments for melanoma.